drugset / Trial / NCT00000235

Alternate Day Buprenorphine Administration, Phase XII - 17

NCT00000235

CrossoverTreatment

Summary

The purpose of this study is to determine if six times daily buprenorphine dose is effective in achieving 120 hour buprenorphine dosing.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified